TY - JOUR
T1 - Inducing an anergic state in mast cells and basophils without secretion
AU - MacGlashan, Donald
AU - Undem, Bradley J.
N1 - Funding Information:
Supported by the National Institutes of Health, grant AI20253.
PY - 2008/6
Y1 - 2008/6
N2 - Background: IgE-mediated secretion from mast cells or basophils depends on the activity of both spleen tyrosine kinase (syk) and phosphatidyl inositol 3′ kinase (PI3K), but several specific downregulatory pathways (eg, loss of syk expression) do not. Objective: We tested whether stimulation with antigen in the presence of a syk inhibitor (NVP-QAB205) would ablate secretion while simultaneously allowing anergy. Methods: The anergic or desensitized state in human basophils, cultured-derived mast cells, and in situ stimulated airway mast cells (in organ baths) was assessed after stimulation with antigen in the presence of syk inhibitor. Results: Antigen caused 35 ± 7% and 62 ± 10% histamine release from basophils and mast cells, respectively, and it caused an 87 ± 5% histamine/leukotriene D4-dependent contraction of human isolated bronchi. All of these responses were blocked >95% by the syk inhibitor. Rechallenging the preparations with antigen, after first washing out the syk inhibitor and antigen, revealed that near complete anergy (92% to 100%) occurred in each case. A similar result was found when using a PI3K inhibitor, LY294002, in studies of basophils. Conclusion: Although the syk inhibitor nearly abolished the antigen-induced secretion from mast cells and basophils, it had little effect on the pathways involved in anergy. These results suggest that syk and PI3K are not involved in downregulation leading to anergy.
AB - Background: IgE-mediated secretion from mast cells or basophils depends on the activity of both spleen tyrosine kinase (syk) and phosphatidyl inositol 3′ kinase (PI3K), but several specific downregulatory pathways (eg, loss of syk expression) do not. Objective: We tested whether stimulation with antigen in the presence of a syk inhibitor (NVP-QAB205) would ablate secretion while simultaneously allowing anergy. Methods: The anergic or desensitized state in human basophils, cultured-derived mast cells, and in situ stimulated airway mast cells (in organ baths) was assessed after stimulation with antigen in the presence of syk inhibitor. Results: Antigen caused 35 ± 7% and 62 ± 10% histamine release from basophils and mast cells, respectively, and it caused an 87 ± 5% histamine/leukotriene D4-dependent contraction of human isolated bronchi. All of these responses were blocked >95% by the syk inhibitor. Rechallenging the preparations with antigen, after first washing out the syk inhibitor and antigen, revealed that near complete anergy (92% to 100%) occurred in each case. A similar result was found when using a PI3K inhibitor, LY294002, in studies of basophils. Conclusion: Although the syk inhibitor nearly abolished the antigen-induced secretion from mast cells and basophils, it had little effect on the pathways involved in anergy. These results suggest that syk and PI3K are not involved in downregulation leading to anergy.
KW - Desensitization
KW - phosphatidyl-inositol 3′ kinase
KW - spleen tyrosine kinase
UR - http://www.scopus.com/inward/record.url?scp=44649087041&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=44649087041&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2008.04.019
DO - 10.1016/j.jaci.2008.04.019
M3 - Article
C2 - 18539198
AN - SCOPUS:44649087041
SN - 0091-6749
VL - 121
SP - 1500-1506.e4
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 6
ER -